Inj, micafungin (baxter)
Products billed under this code include Micafungin In Sodium Chloride.
Payment limit per 1 MG, by effective quarter, 2Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Micafungin In Sodium Chloride.
Payment limit per 1 MG, by effective quarter, 2Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Micafungin In Sodium Chloride | Baxter Healthcare Corporation | 00338-9051-12 | 600 | $200.40 |
| Micafungin In Sodium Chloride | Baxter Healthcare Corporation | 00338-9053-12 | 1200 | $400.80 |
| Micafungin In Sodium Chloride | Baxter Healthcare Corporation | 00338-9055-10 | 1500 | $501.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.334 | −$0.114 | 1 MG | Inj, micafungin (baxter) | v1, posted September 17, 2026 |
| 3Q26 | $0.448 | +$0.083 | 1 MG | Inj, micafungin (baxter) | v1, posted September 15, 2026 |
| 2Q26 | $0.365 | −$0.048 | 1 MG | Inj, micafungin (baxter) | v1, posted September 15, 2026 |
| 1Q26 | $0.413 | −$0.076 | 1 MG | Inj, micafungin (baxter) | v1, posted September 15, 2026 |
| 4Q25 | $0.489 | −$0.022 | 1 MG | Inj, micafungin (baxter) | v1, posted September 8, 2026 |
| 3Q25 | $0.511 | −$0.127 | 1 MG | Inj, micafungin (baxter) | v1, posted March 10, 2026 |
| 2Q25 | $0.638 | – | 1 MG | Inj, micafungin (baxter) | v1, posted March 10, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.